193 related articles for article (PubMed ID: 9845709)
1. Photopheresis for the prevention of rejection in cardiac transplantation. Photopheresis Transplantation Study Group.
Barr ML; Meiser BM; Eisen HJ; Roberts RF; Livi U; Dall'Amico R; Dorent R; Rogers JG; Radovancević B; Taylor DO; Jeevanandam V; Marboe CC
N Engl J Med; 1998 Dec; 339(24):1744-51. PubMed ID: 9845709
[TBL] [Abstract][Full Text] [Related]
2. Prevention of rejection in cardiac transplantation by blockade of the interleukin-2 receptor with a monoclonal antibody.
Beniaminovitz A; Itescu S; Lietz K; Donovan M; Burke EM; Groff BD; Edwards N; Mancini DM
N Engl J Med; 2000 Mar; 342(9):613-9. PubMed ID: 10699160
[TBL] [Abstract][Full Text] [Related]
3. OKT3 induction and steroid-free maintenance immunosuppression for treatment of high-risk heart transplant recipients.
Prieto M; Lake KD; Pritzker MR; Jorgensen CR; Arom KV; Love KR; Emery RW
J Heart Lung Transplant; 1991; 10(6):901-11. PubMed ID: 1661608
[TBL] [Abstract][Full Text] [Related]
4. Reduction of the incidence of rejection by adjunct immunosuppression with photochemotherapy after heart transplantation.
Meiser BM; Kur F; Reichenspurner H; Wagner F; Boos KS; Vielhauer S; Weiss M; Rohrbach H; Kreuzer E; Uberfuhr P
Transplantation; 1994 Feb; 57(4):563-8. PubMed ID: 8116042
[TBL] [Abstract][Full Text] [Related]
5. Effectivity of a T-cell-adapted induction therapy with anti-thymocyte globulin (Sangstat).
Koch A; Daniel V; Dengler TJ; Schnabel PA; Hagl S; Sack FU
J Heart Lung Transplant; 2005 Jun; 24(6):708-13. PubMed ID: 15949731
[TBL] [Abstract][Full Text] [Related]
6. Decreasing incidence of coronary disease in pediatric cardiac transplant recipients using increased immunosuppression.
Addonizio LJ; Hsu DT; Douglas JF; Kichuk MR; Michler RE; Quaegebeur JM; Smith CR; Rose EA
Circulation; 1993 Nov; 88(5 Pt 2):II224-9. PubMed ID: 8222158
[TBL] [Abstract][Full Text] [Related]
7. A prospective randomized controlled study on the efficacy and tolerance of two antilymphocytic globulins in the prevention of rejection in first-heart transplant recipients.
Schnetzler B; Leger P; Völp A; Dorent R; Pavie A; Gandjbakhch I
Transpl Int; 2002 Jun; 15(6):317-25. PubMed ID: 12072903
[TBL] [Abstract][Full Text] [Related]
8. Anti-CD3 monoclonal antibody induction therapy. Immunological equivalency with triple-drug therapy in heart transplantation.
Barr ML; Sanchez JA; Seche LA; Schulman LL; Smith CR; Rose EA
Circulation; 1990 Nov; 82(5 Suppl):IV291-4. PubMed ID: 2121387
[TBL] [Abstract][Full Text] [Related]
9. Combined antiviral and immunoglobulin therapy as prophylaxis against cytomegalovirus infection after heart transplantation.
Valenza M; Czer LS; Pan SH; Aleksic I; Freimark D; Harasty DA; Admon D; Barath P; Blanche C; Trento A
J Heart Lung Transplant; 1995; 14(4):659-65. PubMed ID: 7578172
[TBL] [Abstract][Full Text] [Related]
10. Methotrexate or total lymphoid radiation for treatment of persistent or recurrent allograft cellular rejection: a comparative study.
Ross HJ; Gullestad L; Pak J; Slauson S; Valantine HA; Hunt SA
J Heart Lung Transplant; 1997 Feb; 16(2):179-89. PubMed ID: 9059929
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-2-receptor blockade with daclizumab to prevent acute rejection in renal transplantation. Daclizumab Triple Therapy Study Group.
Vincenti F; Kirkman R; Light S; Bumgardner G; Pescovitz M; Halloran P; Neylan J; Wilkinson A; Ekberg H; Gaston R; Backman L; Burdick J
N Engl J Med; 1998 Jan; 338(3):161-5. PubMed ID: 9428817
[TBL] [Abstract][Full Text] [Related]
12. Prophylactic therapy for rejection after cardiac transplantation. A comparison of rabbit antithymocyte globulin and OKT3.
Kirklin JK; Bourge RC; White-Williams C; Naftel DC; Thomas FT; Thomas JM; Phillips MG
J Thorac Cardiovasc Surg; 1990 Apr; 99(4):716-24. PubMed ID: 2108282
[TBL] [Abstract][Full Text] [Related]
13. A randomized, placebo-controlled trial with anti-interleukin-2 receptor antibody for immunosuppressive induction therapy after liver transplantation.
Langrehr JM; Glanemann M; Guckelberger O; Klupp J; Neumann U; Machens C; Lohmann R; Knoop M; Lobeck H; Schlag H; Keck H; Settmacher U; Bechstein WO; Neuhaus PJ
Clin Transplant; 1998 Aug; 12(4):303-12. PubMed ID: 9686324
[TBL] [Abstract][Full Text] [Related]
14. An open randomized study comparing immunosuppression therapy initiated before or after kidney transplantation in haploidentical living recipients.
Câmara NO; Dias MF; Pacheco-Silva A
Clin Transplant; 2004 Aug; 18(4):450-5. PubMed ID: 15233825
[TBL] [Abstract][Full Text] [Related]
15. FK506 effectiveness in reducing acute rejection after heart transplantation: a prospective randomized study.
Rinaldi M; Pellegrini C; Martinelli L; Goggi C; Gavazzi A; Campana C; Arbustini E; Grossi P; Regazzi M; Ippoliti G; Vigano M
J Heart Lung Transplant; 1997 Oct; 16(10):1001-10. PubMed ID: 9361242
[TBL] [Abstract][Full Text] [Related]
16. The effects of HLA mismatching and immunosuppressive therapy on early rejection outcome in pediatric heart transplant recipients.
Herzberg GZ; Rossi AF; Courtney M; Gelb BD
J Heart Lung Transplant; 1998 Dec; 17(12):1195-200. PubMed ID: 9883760
[TBL] [Abstract][Full Text] [Related]
17. Ketoconazole to reduce the need for cyclosporine after cardiac transplantation.
Keogh A; Spratt P; McCosker C; Macdonald P; Mundy J; Kaan A
N Engl J Med; 1995 Sep; 333(10):628-33. PubMed ID: 7637723
[TBL] [Abstract][Full Text] [Related]
18. Induction therapy after cardiac transplantation: a comparison of anti-thymocyte globulin and daclizumab in the prevention of acute rejection.
Carlsen J; Johansen M; Boesgaard S; Andersen CB; Arendrup H; Aldershvilet J; Mortensen SA
J Heart Lung Transplant; 2005 Mar; 24(3):296-302. PubMed ID: 15737756
[TBL] [Abstract][Full Text] [Related]
19. Five-year experience with triple-drug immunosuppressive therapy in cardiac transplantation.
Olivari MT; Kubo SH; Braunlin EA; Bolman RM; Ring WS
Circulation; 1990 Nov; 82(5 Suppl):IV276-80. PubMed ID: 2225416
[TBL] [Abstract][Full Text] [Related]
20. The prognostic impact of immunosuppression and cellular rejection on cardiac allograft vasculopathy: time for a reappraisal.
Mehra MR; Ventura HO; Chambers RB; Ramireddy K; Smart FW; Stapleton DD
J Heart Lung Transplant; 1997 Jul; 16(7):743-51. PubMed ID: 9257256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
